
Epizyme, Inc.
USD1.47
+0.00 (+0.00%)
CEO
Robert Bazemore
IPO Date
2013-05-31
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.49
Prev. Close
$1.47
Day Low
$1.47
Day High
$1.50
52W Low
$0.41
52W High
$5.80
Epizyme (EPZM) Reports Q2 Loss, Tops Revenue Estimates